You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Boehringer Ingelheim
Merck
Dow
Baxter

Last Updated: February 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Eritoran

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Eritoran?

Eritoran is an investigational drug.

There have been 4 clinical trials for Eritoran. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2006.

The most common disease conditions in clinical trials are Insulin Resistance, Hypersensitivity, and Toxemia. The leading clinical trial sponsors are Eisai Inc., The University of Texas Health Science Center at San Antonio, and Nicolas Musi.

Recent Clinical Trials for Eritoran
TitleSponsorPhase
The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic SubjectsNicolas MusiPhase 2
The Role of TLR4 on Lipid-induced Insulin ResistanceThe University of Texas Health Science Center at San AntonioPhase 2
A Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related DonorsEisai Inc.Phase 1

See all Eritoran clinical trials

Clinical Trial Summary for Eritoran

Top disease conditions for Eritoran
Top clinical trial sponsors for Eritoran

See all Eritoran clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Boehringer Ingelheim
Merck
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.